“…These include formal vaccination protocols involving live mutans streptococci (Bowen, 1969) or extracellular molecules (eg, glucosyltransferases, antigen I/II, glucan binding protein) of these same oral bacteria (Schöller et al, 1978;Smith and Taubman, 1996;Yu et al, 1997) as well as passive immunization techniques, where previously produced antibody is applied topically as a means to control the growth of cariogenic species (Hatta et al, 1997;Ma et al, 1998). The Gtfs of S. mutans have long been target molecules to develop an effective vaccine to D Wunder and WH Bowen 290 Oral Diseases aid in the prevention of caries (Carlsson and Krasse, 1968;Bowen et al, 1976;Smith et al, 1979). To date, however, no effective, long-term immunotherapy based on Gtf immunity has been developed (Bowen, 1996).…”